05.23.14
Massachusetts medical device IT specialist Capsule Tech Inc. is launching its SmartLinx line of integration systems designed to link medical devices with patient data in real time.
Capsule's system offers compatibility with over 650 devices, according to its website, and the company partners with more than 60 device and diagnostic makers worldwide, including giants like Johnson & Johnson, GE Healthcare, Roche and others.
Capsule touts the device as "the industry's first medical device information system." According to the Andover, Mass., company, its software and hardware extends beyond linking devices, offering an intelligent system that incorporates data analytics --- a one-stop shop of sorts for consolidating patient needs.
The suite includes a number of products designed to act together, including an administrative Web-based managing system, multiple data collection points, operational analytics, Wi-Fi connectivity and client software for use with hospitals' existing computers.
"In launching SmartLinx, Capsule is addressing requests from healthcare organizations to do more with their medical device data--to provide early identification and notification of patient deterioration and sepsis detection, and to help them better manage the life of their connected devices, among a number of capabilities," Capsule chief marketing and sales officer Stuart Long said in a statement.
Founded in 1997, Capsule's Neuron touch-screen bedside device connectivity system led the company's offerings in 2013 for a 24 percent increase in revenue. In January, medical device integration competitor Isirona was acquired by healthcare IT firm NantHealth.
"Unlike the laboratory, cardiology, radiology and other various types of hospital information systems that comprise a system of components that manage and provide a variety of services for their users, medical devices are not managed as a system, yet they provide the most accurate, real-time feed of a patient's vital signs and other critical biometric data," Long said. "By taking these devices from just moving data to enabling real-time surveillance and useful analytics of the data, the impact on the quality and cost of care is profound."
Capsule's system offers compatibility with over 650 devices, according to its website, and the company partners with more than 60 device and diagnostic makers worldwide, including giants like Johnson & Johnson, GE Healthcare, Roche and others.
Capsule touts the device as "the industry's first medical device information system." According to the Andover, Mass., company, its software and hardware extends beyond linking devices, offering an intelligent system that incorporates data analytics --- a one-stop shop of sorts for consolidating patient needs.
The suite includes a number of products designed to act together, including an administrative Web-based managing system, multiple data collection points, operational analytics, Wi-Fi connectivity and client software for use with hospitals' existing computers.
"In launching SmartLinx, Capsule is addressing requests from healthcare organizations to do more with their medical device data--to provide early identification and notification of patient deterioration and sepsis detection, and to help them better manage the life of their connected devices, among a number of capabilities," Capsule chief marketing and sales officer Stuart Long said in a statement.
Founded in 1997, Capsule's Neuron touch-screen bedside device connectivity system led the company's offerings in 2013 for a 24 percent increase in revenue. In January, medical device integration competitor Isirona was acquired by healthcare IT firm NantHealth.
"Unlike the laboratory, cardiology, radiology and other various types of hospital information systems that comprise a system of components that manage and provide a variety of services for their users, medical devices are not managed as a system, yet they provide the most accurate, real-time feed of a patient's vital signs and other critical biometric data," Long said. "By taking these devices from just moving data to enabling real-time surveillance and useful analytics of the data, the impact on the quality and cost of care is profound."